Literature DB >> 26615528

The ultra-slow NAT2*6A haplotype is associated with reduced higher cognitive functions in an elderly study group.

Silvia Selinski1, Stephan Getzmann2, Patrick D Gajewski3, Meinolf Blaszkewicz4, Jan G Hengstler5, Michael Falkenstein6, Klaus Golka7.   

Abstract

N-Acetyltransferase 2 (NAT2) genotype is associated with age-related declines in basic sensory hearing functions. However, the possible modulatory role of NAT2 for higher cognitive functions has not yet been studied. We tested auditory goal-directed behavior and attentional control in 120 NAT2 genotyped subjects (63-88 years), using an auditory distraction paradigm in which participants responded to the duration of long and short tone stimuli. We studied involuntary shifts in attention to task-irrelevant deviant stimuli and applied event-related potentials (ERPs) to examine which cognitive subprocesses are affected by NAT2 status on a neurophysiological level. Relative to the standard stimuli, deviant stimuli decreased performance in the recently described ultra-slow acetylators (NAT2*6A and *7B): The increase in error-corrected reaction times (a combined measure of response speed and accuracy) in ultra-slow acetylators (254 ms increase) was more than twice as high as in the rapid acetylator reference group (111 ms increase; p < 0.01). The increase was still higher than in the other slow acetylators (149 ms increase, p < 0.05). In addition, clear differences were found in the ERP results: Ultra-slow acetylators showed deficits specifically in the automatic detection of changes in the acoustic environment as evidenced by reduced mismatch negativity (MMN, p < 0.005 compared to rapid acetylators). Refocussing of attention after a distracting event was also impaired in the ultra-slow acetylators as evidenced by a reduced re-orienting negativity (RON, p < 0.01 compared to rapid acetylators). In conclusion, the ultra-slow acetylation status was associated with reduced higher cognitive functions.

Entities:  

Keywords:  Aging; Auditory distraction; Cognitive flexibility; Event-related potentials; N-Acetyltransferase 2

Mesh:

Substances:

Year:  2015        PMID: 26615528     DOI: 10.1007/s00204-015-1635-1

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  6 in total

1.  Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.

Authors:  David W Hein; Mark A Doll
Journal:  Arch Toxicol       Date:  2017-05-18       Impact factor: 5.153

2.  N-acetyltransferase 2 enzyme genotype-phenotype discordances in both HIV-negative and HIV-positive Nigerians.

Authors:  Olayinka A Kotila; Olufunmilayo I Fawole; Olufunmilayo I Olopade; Adejumoke I Ayede; Adeyinka G Falusi; Chinedum P Babalola
Journal:  Pharmacogenet Genomics       Date:  2019-07       Impact factor: 2.089

3.  Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes.

Authors:  Mark A Doll; David W Hein
Journal:  Arch Toxicol       Date:  2017-05-17       Impact factor: 5.153

4.  Functional Characterization of the Effects of N-acetyltransferase 2 Alleles on N-acetylation of Eight Drugs and Worldwide Distribution of Substrate-Specific Diversity.

Authors:  Koya Fukunaga; Ken Kato; Takuji Okusaka; Takeo Saito; Masashi Ikeda; Teruhiko Yoshida; Hitoshi Zembutsu; Nakao Iwata; Taisei Mushiroda
Journal:  Front Genet       Date:  2021-03-18       Impact factor: 4.599

5.  Evaluation of Genetic Polymorphisms of N-acetyltransferase 2 and Relation with Chronic Myeloid Leukemia.

Authors:  Entesar M Tebien; Hiba B Khalil; Jeremy Mills; Abozer Y Elderdery
Journal:  Asian Pac J Cancer Prev       Date:  2020-12-01

6.  Highlight report: Occupational urinary bladder cancer.

Authors:  H M Bolt
Journal:  EXCLI J       Date:  2017-12-19       Impact factor: 4.068

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.